Historical record - last NADAC effective date: 10/17/2018
Product Information
AMLODIPINE-BENAZEPRIL 2.5-10 is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1687 per EA under NDC 65862058205. Its NADAC has been published 256 times since Dec 5, 2013.
FDA first approved this application on Sep 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 10 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862058205
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/17/2018
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202239FDA Approved
9/5/2012
TE Code
AB
On Market Since
9/5/2012
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has been published 256 times since Dec 5, 2013, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1687 per EA |
|---|---|
| All-time high | $0.6878 (May 14, 2014) |
| All-time low | $0.1442 (Sep 20, 2017) |
| Median price | $0.5386 |
| Average price | $0.4580 |
| Largest weekly change | +58.1% (Sep 19, 2018) |
| Weeks tracked | 256 |
| Tracking since | Dec 5, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-75.2%
Last surveyed Oct 24, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 2.5-10?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 2.5-10, manufactured by Aurobindo Pharma Limited, is $0.1687 per EA (NDC 65862058205), effective Oct 24, 2018.
How has the price of AMLODIPINE-BENAZEPRIL 2.5-10 changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has declined 75.2%. It has been tracked across 256 weekly CMS publications since Dec 5, 2013.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 2.5-10?
Since Dec 5, 2013, the NADAC for AMLODIPINE-BENAZEPRIL 2.5-10 has ranged from a low of $0.1442 (Sep 20, 2017) to a high of $0.6878 (May 14, 2014), with a median of $0.5386 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 2.5-10?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-BENAZEPRIL 2.5-10, is $0.1013 per EA — about 40% below AMLODIPINE-BENAZEPRIL 2.5-10.
Who manufactures AMLODIPINE-BENAZEPRIL 2.5-10?
AMLODIPINE-BENAZEPRIL 2.5-10 (NDC 65862058205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.